Anchalee Avihingsanon

Anchalee Avihingsanon

254 Phayathai Road
Bangkok, 10330, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 277 publications

Incidence, risk factors, and outcomes of anti-tuberculosis drug-induced hepatotoxicity in people with and without HIV in Thailand and the Philippines.

Incidence, risk factors, and outcomes of anti-tuberculosis drug-induced hepatotoxicity in people with and without HIV in Thailand and the Philippines.

Journal: Asian biomedicine : research, reviews and news
Published: August 01, 2026

Trends in frequency of HIV viral load and CD4 cell count monitoring among Asian cohort of adults with HIV: an analysis of the TREAT Asia HIV Observational Database, 2003-2018.

Trends in frequency of HIV viral load and CD4 cell count monitoring among Asian cohort of adults with HIV: an analysis of the TREAT Asia HIV Observational Database, 2003-2018.

Journal: medRxiv : the preprint server for health sciences
Published: April 03, 2026

A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs.

A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs.

Journal: Hepatology communications
Published: March 20, 2026

Risk factors for advanced liver fibrosis among people living with HIV: a 5-year longitudinal study in Thailand.

Risk factors for advanced liver fibrosis among people living with HIV: a 5-year longitudinal study in Thailand.

Journal: AIDS care
Published: March 03, 2026

Prevalence and Mortality due to Mycobacterium tuberculosis Bloodstream Infection in Adults With HIV: A Multicountry Prospective Cohort Study.

Prevalence and Mortality due to Mycobacterium tuberculosis Bloodstream Infection in Adults With HIV: A Multicountry Prospective Cohort Study.

Journal: Open forum infectious diseases
Published: February 25, 2026

B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

Journal: AIDS research and therapy
Published: February 11, 2026

Navigating the Data Gaps of Ageing Among Women Living With HIV.

Navigating the Data Gaps of Ageing Among Women Living With HIV.

Journal: Journal of the International AIDS Society
Published: January 30, 2026

Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.

Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.

Journal: The lancet. HIV
Published: January 12, 2026

Thailand's progress toward long-acting PrEP.

Thailand's progress toward long-acting PrEP.

Journal: The lancet. HIV
Published: January 04, 2026

Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.

Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 26, 2025

Burden of Prefrailty and Frailty in Older People With and Without HIV in Thailand.

Burden of Prefrailty and Frailty in Older People With and Without HIV in Thailand.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 26, 2025

Letter to the Editor Burden of Pre-Frailty and Frailty in older People with and without HIV in Thailand.

Letter to the Editor Burden of Pre-Frailty and Frailty in older People with and without HIV in Thailand.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 26, 2025
Showing 1-12 of 277

Last Updated: 09/26/2026